EUVIMEDEUVIMED entdecken
Open Access

Sevoflurane alleviates hypoxia/reoxygenation-induced myocardial cell injury by regulating miR-93-5p

Qiang Li, Xibao Shi, Jinping Li, Ying Chen

Toxicology Research · 05.07.2025 · 14 (4)

DOI: 10.1093/toxres/tfaf081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicology Research, online erschienen am 07.07.2025. Verfasst von Qiang Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Ruijin 2 Road, Huangpu District, Shanghai 2…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to investigate the action of miR-93-5p in sevoflurane (Sev) preconditioning to protect against hypoxia/reoxygenation (H/R)-induced myocardial cell injury. H9c2 cells were preconditioned with Sev at concentrations of 1%, 2% and 4%, and subjected to H/R induction to establish the model. RT-qPCR was used to test miR-93-5p and NPAS2 levels. CCK8 assay and flow cytometry were used to detect cell viability and apoptosis. ELISA assays were used to measure myocardial injury markers (cTnI, CK-MB, MYO), as well as inflammatory factors (IL-6, IL-β, TNF-α). SOD and MDA kits were performed to detect oxidative stress levels. To investigate the impact of miR-93-5p on the protective effects of Sev pretreatment, we conducted transfection of miR-93-5p mimic. The connection of miR-93-5p with NPAS2 was confirmed using luciferase reporter gene assay. Our findings revealed that H/R treatment reduced cell viability, but Sev pretreatment enhanced it. In addition, Sev preconditioning reduced H/R-induced apoptosis, cTnI, CK-MB, MYO, MDA, IL-6, IL-β, and TNF-α levels, while elevated SOD levels. The miR-93-5p levels elevated with prolonged hypoxia time, but decreased with higher Sev pretreatment concentration. Transfection of miR-93-5p mimic attenuated protective efficacy by Sev preconditioning in myocardial cells. Besides, miR-93-5p targeted NPAS2 and negatively regulated it. In conclusion, our study demonstrated that sevoflurane preconditioning attenuated H/R-induced myocardial cells injury by modulating miR-93-5p.

Schlagwörter

Stichwörter der Autor:innen

NPAS2hypoxia/reoxygenationmiR-93-5pmyocardial cellsevoflurane

Autor:innen und Institutionen

  • Department of Anesthesiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Ruijin 2 Road, Huangpu District, Shanghai 200025, China.
  • Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 999, Xiwang Road, Jiading District, Shanghai 201801, China.

Zitieren

APA

Li, Q., Shi, X., Li, J., & Chen, Y. (2025). Sevoflurane alleviates hypoxia/reoxygenation-induced myocardial cell injury by regulating miR-93-5p. Toxicology Research, 14(4). https://doi.org/10.1093/toxres/tfaf081

Vancouver

Li Q, Shi X, Li J, Chen Y. Sevoflurane alleviates hypoxia/reoxygenation-induced myocardial cell injury by regulating miR-93-5p. Toxicology Research. 2025;14(4). doi:10.1093/toxres/tfaf081

BibTeX
@article{Li2025,
  author = {Li, Qiang and Shi, Xibao and Li, Jinping and Chen, Ying},
  title = {Sevoflurane alleviates hypoxia/reoxygenation-induced myocardial cell injury by regulating miR-93-5p},
  journal = {Toxicology Research},
  year = {2025},
  volume = {14},
  number = {4},
  doi = {10.1093/toxres/tfaf081}
}
Kostenlos starten →